Clin2
NCT07739121Worth exploringRecruiting

Testing AI vs. tumor boards for cancer treatment advice

Breast NeoplasmsLung NeoplasmsUrologic NeoplasmsProstatic NeoplasmsUrinary Bladder NeoplasmsKidney NeoplasmsDigestive System NeoplasmsGenital Neoplasms

Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.

This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must have a synthetic case (not a real patient) in one of these cancers: breast, lung, urological, digestive, or gynecological.
  • The case must include complete details like cancer stage, biomarkers, your ability to perform daily activities, and other health conditions.
  • The case must have a clear, answerable question about which treatment to use, based on current medical guidelines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07234539Enrolling by invitation
AI tool for thyroid cancer management

This study tests an artificial intelligence (AI) helper that assists doctors in managing thyroid cancer. It aims to see if the tool can improve care for patients like you.

Hong Kong
NCT07814872Not yet recruiting
AI-assisted test selection for cancer trial matching

This study uses an AI system to look at your tumor sample and test results to help match you with cancer clinical trials that might be a good fit. It aims to make it easier for doctors to find the most relevant trials for you based on your cancer's specific traits.

Boston, Massachusetts
NCT07063667Not yet recruiting
AI-assisted diagnosis for early breast cancer

This trial uses artificial intelligence (AI) to help doctors more accurately identify early-stage breast cancer from test results. It could lead to faster and more precise diagnosis, which may help you get the right treatment sooner.

Chongqing, Chongqing Municipality
NCT07746830Not yet recruiting
Artificial intelligence compared with cancer team decisions

This study tests whether a computer-based tool can help doctors make treatment decisions for stomach, colon, or rectal cancer. It compares the computer's suggestions with the recommendations of a team of cancer specialists.

Shanghai, Shanghai Municipality
NCT07595107Recruiting
Using AI to support rectal cancer treatment decisions

This study uses an AI tool to help doctors make treatment decisions for rectal cancer. It looks at MRI reports and other medical information to suggest the best next steps, like surgery, radiation, or chemotherapy.

Jinan, Shandong
NCT07378358Recruiting
AI for urology diagnosis and treatment

This study is testing how well AI can help with diagnosis and treatment by looking at medical records of patients from four hospitals, specifically those with urological conditions. It's a way to see if AI can improve care without needing any new tests or visits.

Fuzhou

Hear when a new Breast Neoplasms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.